SI2916852T1 - Porozni silicijev dioksid za uporabo kot farmacevtska ali prehranska aktivna učinkovina - Google Patents

Porozni silicijev dioksid za uporabo kot farmacevtska ali prehranska aktivna učinkovina

Info

Publication number
SI2916852T1
SI2916852T1 SI201331885T SI201331885T SI2916852T1 SI 2916852 T1 SI2916852 T1 SI 2916852T1 SI 201331885 T SI201331885 T SI 201331885T SI 201331885 T SI201331885 T SI 201331885T SI 2916852 T1 SI2916852 T1 SI 2916852T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical
active ingredient
porous silica
silica material
dietary active
Prior art date
Application number
SI201331885T
Other languages
English (en)
Slovenian (sl)
Inventor
Robert Csikasz
Tore Bengtsson
Natalia Kupferschmidt
Alfonso E Garcia-Bennett
Original Assignee
Sigrid Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigrid Therapeutics Ab filed Critical Sigrid Therapeutics Ab
Publication of SI2916852T1 publication Critical patent/SI2916852T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015Inorganic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/113Silicon oxides; Hydrates thereof
    • C01B33/12Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/12Surface area
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/14Pore volume
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/16Pore diameter
    • C01P2006/17Pore diameter distribution
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Silicon Compounds (AREA)
SI201331885T 2012-11-06 2013-11-06 Porozni silicijev dioksid za uporabo kot farmacevtska ali prehranska aktivna učinkovina SI2916852T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261723019P 2012-11-06 2012-11-06
EP13795191.9A EP2916852B1 (en) 2012-11-06 2013-11-06 A porous silica material for use as a pharmaceutical or dietary active ingredient
PCT/EP2013/073200 WO2014072363A1 (en) 2012-11-06 2013-11-06 A porous silica material for use as a pharmaceutical or dietary active ingredient

Publications (1)

Publication Number Publication Date
SI2916852T1 true SI2916852T1 (sl) 2021-08-31

Family

ID=49639855

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331885T SI2916852T1 (sl) 2012-11-06 2013-11-06 Porozni silicijev dioksid za uporabo kot farmacevtska ali prehranska aktivna učinkovina

Country Status (20)

Country Link
US (2) US10695294B2 (https=)
EP (2) EP3892285A3 (https=)
JP (2) JP6421124B2 (https=)
CN (2) CN113069467A (https=)
AU (1) AU2013343565B2 (https=)
BR (1) BR112015010118A2 (https=)
CA (3) CA3024640A1 (https=)
CY (1) CY1124471T1 (https=)
DK (1) DK2916852T3 (https=)
ES (1) ES2878017T3 (https=)
HR (1) HRP20211036T1 (https=)
HU (1) HUE055017T2 (https=)
IL (1) IL238538B (https=)
LT (1) LT2916852T (https=)
PH (1) PH12015501010B1 (https=)
PL (1) PL2916852T3 (https=)
PT (1) PT2916852T (https=)
SI (1) SI2916852T1 (https=)
WO (1) WO2014072363A1 (https=)
ZA (1) ZA201502979B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3024640A1 (en) 2012-11-06 2014-05-15 Sigrid Therapeutics Ab A porous silica material for use as a pharmaceutical or dietary active ingredient
EP2934495B1 (en) * 2012-12-21 2017-07-19 National Health Research Institutes Mesoporous silica nanoparticles for oil absorption
US20200129444A1 (en) * 2017-07-13 2020-04-30 Carnegie Mellon University Method of Increasing Epithelial Permeability Using Nanoparticles
US20210085589A1 (en) * 2017-12-13 2021-03-25 L.I.Co.Rice S.R.L. Complex between lactoferrin and silica, process for the production thereof, and composition thereof for oral hygiene
GB201803363D0 (en) * 2018-03-01 2018-04-18 Sigrid Therapeutics Ab New materials and uses thereof
KR20210153080A (ko) * 2019-04-15 2021-12-16 나노로지카 에이비 퇴행성 신경질환, 뉴런 및 교세포의 치료, 예방 및/또는 퇴행 연기에 사용하기 위한 빈 다공성 입자.
CN110314151B (zh) * 2019-08-02 2020-06-02 深圳国佳产业基金管理有限公司 医用介孔二氧化硅材料及其应用
WO2021062538A1 (en) * 2019-09-30 2021-04-08 Zeroignition Technologies Inc. Thermally insulating and fire retardant material and method for making same
JP7578945B2 (ja) * 2020-10-27 2024-11-07 信越化学工業株式会社 イミダゾールシラン処理シリカからなる胆汁酸吸着剤
CN114195885B (zh) * 2022-01-12 2024-04-26 杭州隆基生物技术有限公司 一种单克隆抗体组合物提纯方法
CN118871077A (zh) 2022-02-04 2024-10-29 西格丽德治疗公司 包含多孔二氧化硅颗粒的口腔护理组合物
JP2025119063A (ja) 2022-04-28 2025-08-14 日本たばこ産業株式会社 無機多孔質材料を含む口腔用組成物
GB202212240D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New formulations and medical uses thereof
GB202212239D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New dietary supplements
CN116747321B (zh) * 2023-06-14 2025-09-05 厦门君德医药科技有限公司 一种接枝改性的介孔二氧化硅及其制备方法和应用
GB202312179D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New compositions and uses
GB202312176D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New uses and methods

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185088A (en) 1977-02-17 1980-01-22 Merck & Co., Inc. Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants
US4180566A (en) 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
US4824672A (en) * 1986-06-06 1989-04-25 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US5401466A (en) * 1993-06-01 1995-03-28 Miles Inc. Device for the direct measurement of low density lipoprotein cholesterol
EP0778027A3 (de) 1995-12-04 1998-04-01 Helmut Univ.-Prof. Dr. Wachter Verwendung von Kieselerde zur Herstellung von Arzneimitteln
EP0911078A1 (en) * 1997-10-20 1999-04-28 Hitachi Metals, Ltd. Photocatalyst-supporting body and photocatalytic apparatus
WO2000000195A1 (en) * 1998-06-30 2000-01-06 Takeda Chemical Industries, Ltd. Pharmaceutical composition for the treatment of diabetes
HK1042051A1 (zh) * 1999-08-16 2002-08-02 Henceforth Hibernia Inc. 包含有催化生物拟态固形物的治疗及预防用药物,以及其制备和使用方法
NZ523684A (en) 2000-07-28 2005-04-29 F New pharmaceutical composition
US7074440B2 (en) * 2002-05-01 2006-07-11 Rulin Xiu Compositions and methods for body weight loss
JP2004345895A (ja) 2003-05-21 2004-12-09 Ajinomoto Co Inc メソポーラスシリカ及びその製造方法
JP2005289853A (ja) 2004-03-31 2005-10-20 Ajinomoto Co Inc 経口リン酸吸着剤
GB0515353D0 (en) 2005-07-27 2005-08-31 Psimedica Ltd Food
KR100857411B1 (ko) 2006-07-21 2008-09-08 한올제약주식회사 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법
CN101939258B (zh) 2008-02-11 2014-05-14 纳诺洛吉卡股份公司 中孔材料的制造方法、这样生产的材料以及中孔材料的用途
TW200936130A (en) * 2008-02-26 2009-09-01 Lundbeck & Co As H Uses of indane compounds
US20110212055A1 (en) * 2008-03-25 2011-09-01 Commissiong John W Neurodegenerative disorders
JP2010065023A (ja) 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび/または脂溶性色素含有粉体
US8778401B2 (en) * 2008-10-28 2014-07-15 Agency For Science, Technology And Research Mesoporous material excipients for poorly aqueous soluble ingredients
DE102009026686A1 (de) * 2009-06-03 2010-12-23 Airbus France Anordnung zum Blitzschutz einer elektronischen Einheit
US20130058987A1 (en) 2010-03-17 2013-03-07 Nanologica Ab Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof
WO2012004291A1 (en) * 2010-07-06 2012-01-12 Nanologica Ab Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients.
GB201212866D0 (en) 2012-07-20 2012-09-05 Formac Pharmaceuticals Nv Dry granulates of mesoporous silica powders
CA3024640A1 (en) 2012-11-06 2014-05-15 Sigrid Therapeutics Ab A porous silica material for use as a pharmaceutical or dietary active ingredient
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
EP2934495B1 (en) 2012-12-21 2017-07-19 National Health Research Institutes Mesoporous silica nanoparticles for oil absorption

Also Published As

Publication number Publication date
WO2014072363A1 (en) 2014-05-15
EP2916852B1 (en) 2021-04-14
PL2916852T3 (pl) 2021-11-02
CA3024640A1 (en) 2014-05-15
PH12015501010A1 (en) 2015-07-27
DK2916852T3 (en) 2021-05-10
US20150258028A1 (en) 2015-09-17
JP6421124B2 (ja) 2018-11-07
AU2013343565A1 (en) 2015-05-21
CA2890171A1 (en) 2014-05-15
CN113069467A (zh) 2021-07-06
JP2019023222A (ja) 2019-02-14
JP6752858B2 (ja) 2020-09-09
BR112015010118A2 (pt) 2017-07-11
PT2916852T (pt) 2021-06-15
CY1124471T1 (el) 2022-07-22
ZA201502979B (en) 2024-09-25
LT2916852T (lt) 2021-06-25
HUE055017T2 (hu) 2021-10-28
IL238538B (en) 2019-06-30
US12121612B2 (en) 2024-10-22
ES2878017T3 (es) 2021-11-18
CA3024460A1 (fr) 2018-11-15
IL238538A0 (en) 2015-06-30
HRP20211036T1 (hr) 2021-10-01
CN105188720A (zh) 2015-12-23
US10695294B2 (en) 2020-06-30
CA2890171C (en) 2019-01-22
US20200390703A1 (en) 2020-12-17
EP2916852A1 (en) 2015-09-16
EP3892285A3 (en) 2021-11-17
AU2013343565B2 (en) 2018-07-26
EP3892285A2 (en) 2021-10-13
PH12015501010B1 (en) 2023-10-20
JP2015536939A (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
DK2916852T3 (en) A porous silica material for use as a pharmaceutical or dietary active ingredient
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
IL269054A (en) A pharmaceutical preparation containing tesimaltone for use in the treatment of 24-NON
IL238713A0 (en) Self-regulating active pharmaceutical ingredient release
PL3181122T3 (pl) Kompozycja farmaceutyczna dazatynibu
ZA201407373B (en) Novel pharmaceutical formulations
ZA201409020B (en) Pharmaceutical formulation
ZA201404035B (en) Microcapsule containing fungicidal active ingredient
ZA201405797B (en) Pharmaceutical dosage form
GB201205164D0 (en) Pharmaceutical compounds
HUE046229T2 (hu) Javított stabilitású gyógyászati készítmény
IL239512A0 (en) Pharmaceutical compounds
GB201202027D0 (en) Pharmaceutical compounds
ZA201406407B (en) Pharmaceutical formulation containing flupirtin
GB201211403D0 (en) Pharmaceutical formulations
GB201211406D0 (en) Pharmaceutical formulations
ZA201502354B (en) Pharmaceutical dosage form
GB201219236D0 (en) Pharmaceutical compounds
GB201213519D0 (en) Pharmaceutical compounds
GB201203253D0 (en) Pharmaceutical compounds